Home
At a glance
Contact us
Home
»
Media
»
Press Releases
Debio 0930
Date
Article Title
04 Aug 2009
Debiopharm Group and Mercury Therapeutics, Inc. sign an exclusive license agreement for the development and commercialisation of Debio 0930 - A first-in-class, small molecule activator of AMPK for treatment of type 2 diabetes
Latest News
09 November 2011
Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease
05 October 2011
The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and outstanding research in the field of cancer
08 September 2011
Debiopharm Group™ presents the ‘Debiopharm Group™ Life Sciences Award 2011’ and two ‘Junior Debiopharm Group™ Awards 2011’ at the ISREC 2011 Life Sciences Symposium
About us
Our business
Responsibility
Careers
Media
Press Releases
Publications
Download center
Events
Debiopharm on
Legal Notice
Credits
Sitemap
© 2012 Debiopharm Group
